Latest filing published 04 Nov 2022 for Edesa Biotech, Inc., €10k.
Insider track record
Kathi Niffenegger: trading record in brief
Kathi Niffenegger is a declared insider of Edesa Biotech, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 8 January 2020 and the latest from 2 November 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 4 November 2022: a share grant of €10k, in Edesa Biotech, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kathi Niffenegger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,888 shares@ US$1.125100.0% of flowCommon SharesSEC:0001654954-22-014746:0
- 609 shares@ US$4.0012.4% of flowCommon SharesSEC:0001654954-20-011986:0
- 1,218 shares@ US$4.1126.9% of flowCommon SharesSEC:0001654954-20-000310:0
3 of 3 declarations
